Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration

MLA

Joanna Q. Hudson, et al. “Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 36, Dec. 2016, pp. 1229–37. EBSCOhost, https://doi.org/10.1002/phar.1866.

APA

Joanna Q. Hudson, G. Christopher Wood, David M Hill, Angela Arnold-Ross, William L. Hickerson, Joseph M. Swanson, Zhe-Yi Hu, S. Casey Laizure, & Bradley A. Boucher. (2016). Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36, 1229–1237. https://doi.org/10.1002/phar.1866

Chicago

Joanna Q. Hudson, G. Christopher Wood, David M Hill, Angela Arnold-Ross, William L. Hickerson, Joseph M. Swanson, Zhe-Yi Hu, S. Casey Laizure, and Bradley A. Boucher. 2016. “Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (December): 1229–37. doi:10.1002/phar.1866.